| 英文别名 |
3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide;3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide Didesmethyl Sumatriptan;3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide (Didesmethyl Sumatriptan);1-(3-(2-Aminoethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide;1-[3-(2-aminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide;1H-Indole-5-methanesulfonamide,3-(2-aminoethyl)-N-methyl-;3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide (Didesmethyl Sumatriptan)
;1-(3-(2-Aminoethyl)-1H-indol-5-yl)-N-met;1H-Indole-5-methanesulfonamide,3-(2-aminoethyl)-N-methyl;2-[5-[[(methylamino)sulphonyl]methyl]-1H-indol-3-yl]ethanamine;3-(2-aminoethyl)-1H-indole-5-yl-N-methyl methane sulphonamide;3-(2-aminoethyl)-N-methyl-1H-indole-5-methanesulphonamide;C-<3-(2-aminoethyl)-1H-indol-5-yl>-N-methylmethanesulphonamide;Didesmethyl sumatriptan;UNII-WE0Q003U63;1H-Indole-5-methanesulfonamide, 3-(2-aminoethyl)-N-methyl-;WE0Q003U63;(3-(2-Aminoethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide;[3-(2-Aminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide;3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide (ACI);[3-(2-Aminoethyl)-1H-indol-5-yl]-N-methylmethanesulphonamide;Sumatriptan impurity, (3-(2-(aminoethyl))-1H-indol-5-yl)-N-methylmethanesulfonamide- [USP];DTXSID90237424;88919-22-6;Q27292582;SUMATRIPTAN IMPURITY, (3-(2-(AMINOETHYL))-1H-INDOL-5-YL)-N-METHYLMETHANESULFONAMIDE- [USP IMPURITY];SUMATRIPTAN SUCCINATE IMPURITY, (3-(2-(AMINOETHYL))-1H-INDOL-5-YL)-N-METHYLMETHANESULFONAMIDE- [USP IMPURITY];Sumatriptan succinate impurity, (3-(2-(aminoethyl))-1H-indol-5-yl)-N-methylmethanesulfonamide- [USP];Sumatriptan succinate specified impurity E [EP];SUMATRIPTAN SUCCINATE IMPURITY E [EP IMPURITY];Sumatriptan EP Impurity E;MFCD08063851;C12H17N3O2S;SCHEMBL5918470;(3-(2-(Aminoethyl))-1H-indol-5-yl)-N-methylmethanesulfonamide;AKOS015920454;AS-18598;STL018673 |